Editable Antibody Cell Lines for Rapid Custom Antibody Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibody manufacturing processes are complex, time-consuming, and costly due to the need for vector construction, clone selection, and stability assessment for each new antibody production, with potential deviations and failures.
Innovation Solution
Development of editable cell lines that express antibody constant regions, allowing for the introduction of variable regions without vector construction, using gene editing proteins to excise and integrate specific sequences, thereby creating a platform for customized antibody production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional vector construction and clone selection methods are used for each new antibody production, then manufacturing precision and reliability are maintained, but manufacturing time and complexity increase significantly
Solution Approach 1:
The patent performs preliminary actions by pre-integrating antibody constant region genes into the cell line genome before actual antibody production is needed. This creates a ready-to-use editable cell line that only requires variable region introduction, eliminating the need for vector construction and clone selection at the time of production.
Solution Approach 2:
The antibody gene is segmented into constant regions (pre-integrated into cell line) and variable regions (introduced later). This segmentation allows the constant regions to be established once in the cell line while enabling flexible exchange of variable regions for different antibodies, reducing repetitive manufacturing steps.
2Reliability
If vector construction and clone selection processes are implemented for each antibody, then manufacturing reliability is ensured, but device complexity and operational difficulty increase
Solution Approach 1:
The cell line is prepared in advance with pre-integrated constant region genes and gene editing machinery, so that when production is needed, only simple variable region introduction is required. This preliminary setup eliminates complex vector construction and clone selection processes while maintaining reliability through stable genomic integration.
3Stability of the object's composition
If traditional multi-staged manufacturing processes are used, then antibody production stability is achieved, but productivity and manufacturing efficiency decrease
Solution Approach 1:
The manufacturing process is segmented into a one-time cell line development phase (integrating constant regions) and a rapid antibody production phase (introducing variable regions). This segmentation maintains stability through stable genomic integration while dramatically improving productivity by eliminating repetitive complex steps.
Solution Approach 2:
The editable cell line serves as a universal platform that can produce multiple different antibodies by simply introducing different variable regions. This multi-functional cell line eliminates the need for separate vector construction and optimization for each antibody, improving both stability and productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces manufacturing time and costs by eliminating the need for vector construction and clone selection, providing a reliable and efficient method for producing customized antibodies.
Implementation Method 1
excising the sequence encoding the variable heavy chain region with a gene editing protein, and excising the variable light chain region sequence with the gene editing protein
Data Source
AI summary
The present disclosure provides editable cell lines, including the use of gene editing proteins to produce the cell lines. The editable cell lines are able to express antibody constant regions that can serve as a platform for the antibody variable regions to produce customized antibody.